Remission of proteinuria in multidrug-resistant idiopathic nephrotic syndrome following immunoglobulin

Elodie Nattes1, Danièle Karaa1, Laurène Dehoux1

  • 1Pediatric Nephrology Unit, Hôpital Robert Debré, APHP, Sorbonne Paris Cité University, Paris, France.

Insights

Multidrug-resistant nephrotic syndrome in children can be treated with immunoglobulin immunoadsorption (IgIA) and B-cell depletion, achieving remission in most patients. However, sustained remission often requires additional immunosuppression.

Area of Science:

  • Pediatric Nephrology
  • Immunology

Background:

  • Idiopathic nephrotic syndrome (INS) resistant to standard treatments like prednisone and calcineurin inhibitors can progress to end-stage renal disease.
  • Multidrug-resistant INS poses a significant therapeutic challenge in pediatric patients.

Purpose of the Study:

  • To evaluate the efficacy of a treatment combining immunoglobulin immunoadsorption (IgIA), intravenous immunoglobulins, and B-cell depletion for multidrug-resistant nephrotic syndrome in children.
  • To report the outcomes and remission rates in this patient cohort.

Main Methods:

  • Patients underwent ten sessions of IgIA and intravenous immunoglobulins over two weeks.
  • Rituximab was administered for patients achieving remission.
  • Treatment outcomes, including proteinuria remission and relapse rates, were monitored.

Main Results:

  • Remission of proteinuria was achieved in 9 out of 14 patients after the initial phase, with 2 additional patients responding after extended treatment.
  • Remission was stable in 3 patients and maintained with additional IgIA and immunosuppression in 6 patients.
  • Two patients relapsed after IgIA withdrawal, and 3 patients (including 2 with genetic podocytopathy) did not respond to treatment.

Conclusions:

  • Immunoglobulin immunoadsorption (IgIA) can induce remission in children with multidrug-resistant nephrotic syndrome, potentially preventing progression to end-stage renal disease.
  • Achieving and maintaining remission often necessitates significant additional immunosuppressive therapy.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
652
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
246
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
329
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.4K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K